FindTrial
Sign In

Comparison of Vanshmul raskriya varti with Triphala raskriya varti in Squamous Blepharitis

Randomized controlled clinical trial to evaluate the efficacy of Vanshmul raskriya varti anjan with Triphala raskriya varti anjan in Squamous Blepharitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025034
Enrollment
60
Registered
2020-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H010- Blepharitis

Interventions

Intervention1: Vanshmul raskriyavartianjan: Group A will be treated with Vanshmul raskriya vartianjan. Dose - 0.1mg. Applied from kaninika to apangsandhi. Given once in a day for 7 consecutive days wh

Sponsors

Principal PDEAs College of Ayurved and Research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having symptoms of squamous blepharitis.

Exclusion criteria

Exclusion criteria: 1.Recently operated patient. 2.One eyed patient. 3.Known lid malignancy. 4.Patient suffering from any lid abnormality.

Design outcomes

Primary

MeasureTime frame
To compare and study the efficacy of vanshmul raskriyavarti anjan once in a day for 7 consecutive days as compared to triphala raskriyavarti anjan for 7 consecutive days in squamous blepharitis.Timepoint: 15 days with follow up on 7th and 15th day.—

Secondary

MeasureTime frame
To observe any serious adverse effects.Timepoint: 15 days with follow up on 7th and 15th day.—

Countries

India

Contacts

Public ContactDr Vidya Shivaji Pandhare

PDEAs College of Ayurved and Research centre, Akurdi, Pune.

aparnabhoite@gmail.com9423585654

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026